Effect of Benign Biopsy Findings on an Artificial Intelligence-Based Cancer Detector in Screening Mammography: Retrospective Case-Control Study.

Journal: JMIR AI
Published Date:

Abstract

BACKGROUND: Artificial intelligence (AI)-based cancer detectors (CAD) for mammography are starting to be used for breast cancer screening in radiology departments. It is important to understand how AI CAD systems react to benign lesions, especially those that have been subjected to biopsy.

Authors

  • Athanasios Zouzos
    Department of Oncology and Pathology, Karolinska Institute, Stockholm, Sweden.
  • Aleksandra Milovanovic
    Department of Oncology and Pathology, Karolinska Institute, Stockholm, Sweden.
  • Karin Dembrower
    Department of Oncology and Pathology, Karolinska Institute, Stockholm, Sweden.
  • Fredrik Strand
    Department of Oncology and Pathology, Karolinska Institute, Stockholm, Sweden.

Keywords

No keywords available for this article.